Jiangsu Solicitude Medical Technology (Group) Co., Ltd. was established in 2019. It is the only high-tech enterprise in China that has completed a full-chain layout in the fields of blood purification and life science membranes and filters.

SMT Group is a national specialized and innovative "small giant" enterprise, a member of the China Blood Purification Materials Industry Association, and a member of the Zhongguan Blood Purification Association (Tribute Standards). It has also been selected as a "Suzhou Unicorn Cultivation Enterprise" and a "Jiangsu Potential Unicorn Enterprise". Up to now, SMT Group has undertaken nine national scientific research projects, including four projects of the Science and Technology Department of the 14th Five-Year Plan (leading one, participating in three), and has been selected for four "Challenge and Award" projects of the first and second batches of biomedical material innovation tasks by the Ministry of Industry and Information Technology and the National Medical Products Administration (leading two, participating two), and has led one "Challenge and Award" project of the Ministry of Industry and Information Technology's key product innovation task for fine chemicals. It covers areas such as "artificial lungs", blood purification polyether sulfone/sulfone membranes, anticoagulant blood purification filters, portable CRRT equipment, and treatment of severe liver failure.

SMT people, with over ten years of research experience in blood purification and medical hollow fiber membranes, have always adhered to the concept of "caring for life and focusing on innovation", based on the "Guanqi Membrane, China's 'Core'" foundation, extending innovation to broader fields of life science, and continuously moving forward to achieve the mission of "letting life regain its brilliance".